share_log

ノイルイミューン・バイオテック:自社創薬パイプラインの優先度再設定及びそれに伴う上場時調達資金使途変更に関するお知らせ

Noile-Immune Biotech: Announcements of individual stocks regarding the re-prioritization of our in-house drug development pipeline and changes in the use of funds raised at the time of listing.

JPX ·  Jun 28 04:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more